EPO Patents = 2

Trademarks = 3

Forward Citations = 7

Loading Chart...

4 inventors (with patents filed for the assignee):

Paul Olson (5 out of 24 patents)

Don W Moss (4 out of 4 patents)

Nicholas Staten (3 out of 3 patents)

4. Alfred Kim (1 out of 1 patent)

5. Donald W Moss (0 patent)

6. Nick Staten (0 patent)

7. Donald Moss (0 patent)

5 patents: Sort by Forward Citations

1. 11029318 - Methods for predicting and treating patients with increased risk of adverse pregnancy outcome (2021-06-08),

2. 9939446 - Lateral flow immunoassay for complement activation and methods of use for point-of-care assessment of complement-associated disorders (2018-04-10),

3. 9182396 - Lateral flow immunoassay for complement activation and methods of use for point-of-care assessment of complement-associated disorders (2015-11-10),

4. 9164088 - Detecting complement activation (2015-10-20),

5. 8865164 - Detecting complement activation (2014-10-21),

Kypha, Inc. is a biotechnology company focused on developing innovative immune diagnostic products for inflammatory diseases. Their solutions help clinicians make more informed treatment decisions and improve patient outcomes. With a strong commitment to research and development, Kypha is dedicated to advancing the field of immune diagnostics.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#292 in St. Louis, MO

#728 in Missouri

#51,570 in US

St. Louis, MO, United States of America

Kypha, Inc.